Cargando…

Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients

AIM: To develop a scale of domains associated with the health-related quality-of-life (HRQOL) in patients with cirrhosis-related ascites. METHODS: We initially undertook literature searches and a qualitative study in order to design a cirrhosis-associated ascites symptom (CAS) scale describing sympt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riedel, Agnete Nordheim, Kimer, Nina, Jensen, Anne-Sofie Houlberg, Dahl, Emilie Kristine, Israelsen, Mads, Aamann, Luise, Gluud, Lise Lotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910548/ https://www.ncbi.nlm.nih.gov/pubmed/29686472 http://dx.doi.org/10.3748/wjg.v24.i15.1650

Ejemplares similares

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series
por: Kimer, Nina, et al.
Publicado: (2020)

Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials
por: Kimer, Nina, et al.
Publicado: (2012)

Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites
por: Alvarado-Tapias, Edilmar, et al.
Publicado: (2018)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism
por: Arya, Rahul, et al.
Publicado: (2023)

Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis
por: Caporali, Cristian, et al.
Publicado: (2021)

Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
por: Kimer, Nina, et al.
Publicado: (2014)

Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studies
por: Hetland, Liv E., et al.
Publicado: (2023)

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
por: Kronborg, Thit Mynster, et al.
Publicado: (2021)

Ascites and Cirrhosis
por: Stott, Hugh
Publicado: (1911)

Guidelines on the management of ascites in cirrhosis
por: Aithal, Guruprasad P, et al.
Publicado: (2021)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

Chylous Ascites and Chylothorax Caused by Constrictive Pericarditis
por: Yu, Guo-Can, et al.
Publicado: (2017)

Operation for the Ascites of Cirrhosis
Publicado: (1899)

Ascites in Cirrhosis of the Liver
Publicado: (1905)

Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
por: Zhong, Hao-Jie, et al.
Publicado: (2019)

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
por: Rinaldi, Luca, et al.
Publicado: (2017)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
por: Lv, Xin-Yue, et al.
Publicado: (2020)

Global epidemiology of cirrhosis — aetiology, trends and predictions
por: Huang, Daniel Q., et al.
Publicado: (2023)

An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
por: Honar, Naser, et al.
Publicado: (2022)

Ascites in Early Alcoholic Cirrhosis of the Liver
por: Weber, F. Parkes
Publicado: (1903)

Management of Ascites in Patients with Cirrhosis: An Update
por: Zaccherini, Giacomo, et al.
Publicado: (2021)

Operative Treatment of Ascites in Cirrhosis of the Liver
Publicado: (1909)

Innovative approaches to the management of ascites in cirrhosis
por: Wong, Florence
Publicado: (2023)

Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk
por: Thakrar, Sonali V, et al.
Publicado: (2017)

Assessment of resting energy expenditure in patients with cirrhosis
por: Ferreira, Shaiane, et al.
Publicado: (2022)

Evaluation of the nutritional status of patients with liver cirrhosis
por: Janota, Barbara, et al.
Publicado: (2023)

Large Variations in Risk of Hepatocellular Carcinoma and Mortality in Treatment Naïve Hepatitis B Patients: Systematic Review with Meta-Analyses
por: Thiele, Maja, et al.
Publicado: (2014)

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation
por: Monteiro, Sofia, et al.
Publicado: (2021)

Case of Hydatid Ascites
por: Long, R.
Publicado: (1825)

Hospital resource intensity and cirrhosis mortality in United States
por: Mathur, Amit K, et al.
Publicado: (2017)

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022)

Tense Ascites in Cirrhosis: Paracentesis With Albumin Infusion Versus Spontaneous Ascites Filtration
por: Robson, Simon C.
Publicado: (1994)

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
por: Stirnimann, G., et al.
Publicado: (2017)

Management of Renal Failure and Ascites in Patients with Cirrhosis
por: Madan, Kaushal, et al.
Publicado: (2011)

Current management of refractory ascites in patients with cirrhosis
por: Zhao, Ruihong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gbpg1rbvlo43v8glsdtdnuqb4v